|
Earlier this month, you received a brief overview of the autologous stem cell procedure specifically for ALS developed by Tecnologico de Monterrey, the internationally acclaimed health sciences, education and biotechnology institution. You can now examine, in depth, the many and varied aspects of this procedure. The following topics are included in this detailed document:
A DISCUSSION OF
STEM CELL TRANSPLANTATION INTO THE FRONTAL MOTOR CORTEX IN ALS PATIENTS
TECNOLOGICO DE MONTERREY SCHOOL OF MEDICINE, MONTERREY, MEXICO
- Background Information of the Stem Cell Transplantation for ALS Patients
- Primary Physician Co-Authors of the Clinical Test Study
- Description of the Procedure
- Safety of the Procedure
- Justification for Usage of CD133(+) Stem Cells
- Duration of Hospitalization
- Funding of Research
- Extra Expenses for those seeking this treatment
- Standard Tests Performed
- Anticipated Results from the Procedure
- Description and Standards of Hospital
- Measurement of Pre- and Post-Procedure Results
- Further Stem Cell Procedure(s)
- Major Protocol Modifications Following Phase I and II Clinical Test Studies
- The City and Tecnologico de Monterrey
- Research Subject Scheduling
- Additional Information
Please go to Discussion of Stem Cell Transplantation for the complete discussion.
The first two international ALS research subjects, both from the US, traveled to Hosptial San Jose Tecnologico (photo shown) in Monterrey, Mexico in early June to participate in this study. They both returned home in mid-June and are following the recommended physical therapy guidelines to encourage neuronal development. In six months, both will return to Monterrey for the followup cranial MRI tractography. Several other international patients have already been scheduled during the months of July and August.
While in Monterrey,Stephen appeared on the television program "Opcion Multiple", the Mexican version of 60 Minutes. Participating in the discussion entitled 'Cellular Therapy and Biotechnology' was Dr. Hector Ramon Martinez, Neurologist and Main Researcher of ALS Stem Cells Transplantaion, Dr. Jorge Moreno Cuevas, Coordinator, Stem Cells therapy Cahir and Dr. Mario Moises Alvarez, Director of the Biotechnology. Excerpts are currently being prepared for viewing on the ALS WORLDWIDE website.
In our son Ben Byer's name and spirit, we mark the anniversary of his death by keeping the flame of his magnificent efforts alive.
Barb and Steve
July 3, 2009
|
